Posted 11 August 2011 - 12:31 PM
Imagine that this approach really works. One goes in for a DNA type of analysis and the doctors create unique T-cell response custom to you and a month later, the CML is dramatically reduced - maybe even eradicated by ones own immune system. You take your TKI bottle and throw it away - all $5,000 worth.
So ... what happens to Gleevec, Sprycel, Tasigna ....etc. etc. Doesn't anyone care about the lost profits of big-Pharma? What about them? It's not fair I tell you. They worked hard to help us (and make billions - but whose counting) - and to suddenly make their drugs obsolete - even useless ...
In the board room of Bristol Meyers Squibb, a business man reports that competitors at the Univ. of Penn - have found a way to elimininate the TKI market. I wonder what they will do.
Here is info on the Doctor and his research interests. It's all about T-cells:
http://www.med.upenn....php/g275/p2328
Diagnosed 11 May 2011 (100% FiSH, 155% PCR)
with b2a2 BCR-ABL fusion transcript coding for the 210kDa BCR-ABL protein
Sprycel: 20 mg per day - taken at lights out with Quercetin and/or Magnesium Taurate
6-8 grams Curcumin C3 complex.
2015 PCR: < 0.01% (M.D. Anderson scale)
2016 PCR: < 0.01% (M.D. Anderson scale)
March 2017 PCR: 0.01% (M.D. Anderson scale)
June 2017 PCR: "undetected"
September 2017 PCR: "undetected"